Bloomsbury Genetic Therapies Limited
Bloomsbury Genetic Therapies Limited is an active company incorporated on 31 August 2021 with the registered office located in Cambridge, Cambridgeshire. Bloomsbury Genetic Therapies Limited was registered 4 years ago.
Status
Active
Active since incorporation
Company No
13593877
Private limited company
Age
4 years
Incorporated 31 August 2021
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Due Soon
Dated 30 August 2024 (1 year ago)
Next confirmation dated 30 August 2025
Due by 13 September 2025 (6 days remaining)
Last change occurred 11 months ago
Accounts
Due Soon
For period 1 Jan ⟶ 31 Dec 2023 (12 months)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2024
Due by 30 September 2025 (23 days remaining)
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Dr Frank Armstrong is a mutual person.
Active
Adrien Felix Lemoine is a mutual person.
Active
Dr Frank Armstrong is a mutual person.
Active
Dr Frank Armstrong is a mutual person.
Active
Dr Frank Armstrong is a mutual person.
Active
Brands
Bloomsbury Genetic Therapies is a clinical-stage biotechnology company focused on developing gene therapy treatments for patients with rare neurological and metabolic diseases.
Financials
Net Assets, Total Assets & Total Liabilities (2022–2023)
Period Ended
31 Dec 2023
For period 31 Dec ⟶ 31 Dec 2023
Traded for 12 months
Cash in Bank
£2.43M
Decreased by £1.65M (-40%)
Turnover
Unreported
Same as previous period
Employees
6
Increased by 2 (+50%)
Total Assets
£2.94M
Decreased by £1.35M (-31%)
Total Liabilities
-£1.65M
Increased by £1.33M (+417%)
Net Assets
£1.3M
Decreased by £2.67M (-67%)
Debt Ratio (%)
56%
Increased by 48.52% (+653%)
Get Credit Report
Discover Bloomsbury Genetic Therapies Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
